In conclusion, our findings indicate that ACTA2-AS1 may function as a tumor suppressor in PTC, at least partly by regulating miR-4428-dependent KLF9 expression as demonstrated in the graphical abstract (Fig. 8). Here, KLF9 is linked to neoplasm.